AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionViolich Capital Management, Inc.
Latest Disclosed Ownership110,479 shares
Latest Disclosed Value $ 24,028,078
Violich Capital Management, Inc. reports 0.82% decrease in ownership of 4AB / AbbVie Inc.

On April 8, 2026 - Violich Capital Management, Inc. filed a 13F-HR form disclosing ownership of 110,479 shares of AbbVie Inc. (BG:4AB) valued at $24,028,078 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 111,394 shares of AbbVie Inc.. This represents a change in shares of -0.82% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F Abbvie COM 00287Y109 110,479 -915 -0.82 24,028 -5.59 2.8088
2026-02-03 2025-12-31 13F Abbvie COM 00287Y109 111,394 1,018 0.92 25,452 -0.41 2.8404
2025-10-29 2025-09-30 13F Abbvie COM 00287Y109 110,376 6,231 5.98 25,556 32.20 3.0408
2025-07-29 2025-06-30 13F Abbvie COM 00287Y109 104,145 -12,770 -10.92 19,331 80,445.83 2.7204
2025-05-02 2025-03-31 13F AbbVie COM 00287Y109 116,915 -182 -0.16 24 20.00 3.3048
2025-01-29 2024-12-31 13F AbbVie COM 00287Y109 117,097 -164 -0.14 21 -13.04 2.7066
2024-10-18 2024-09-30 13F AbbVie COM 00287Y109 117,261 775 0.67 23 21.05 3.0101
2024-07-25 2024-06-30 13F AbbVie COM 00287Y109 116,486 1,040 0.90 20 -9.52 2.6999
2024-04-30 2024-03-31 13F AbbVie COM 00287Y109 115,446 4,615 4.16 21 23.53 3.0085
2024-01-26 2023-12-31 13F AbbVie COM 00287Y109 110,831 567 0.51 17 6.25 2.7880
2023-10-12 2023-09-30 13F AbbVie COM 00287Y109 110,264 -5,474 -4.73 16 6.67 2.8043
2023-07-25 2023-06-30 13F AbbVie COM 00287Y109 115,738 -3,500 -2.94 16 -21.05 2.5128
2023-04-18 2023-03-31 13F AbbVie COM 00287Y109 119,238 -85 -0.07 19 0.00 3.2386
2023-01-24 2022-12-31 13F AbbVie COM 00287Y109 119,323 -200 -0.17 19 -99.88 3.4240
2022-10-17 2022-09-30 13F AbbVie COM 00287Y109 119,523 -136 -0.11 16,041 -12.47 3.0217
2022-07-25 2022-06-30 13F AbbVie COM 00287Y109 119,659 -212 -0.18 18,327 -5.69 3.2109
2022-04-25 2022-03-31 13F AbbVie COM 00287Y109 119,871 -1,002 -0.83 19,432 18.73 2.8697
2022-01-26 2021-12-31 13F AbbVie COM 00287Y109 120,873 1,642 1.38 16,366 27.25 2.3509
2021-10-12 2021-09-30 13F AbbVie COM 00287Y109 119,231 3,590 3.10 12,861 -1.27 2.0682
2021-07-29 2021-06-30 13F AbbVie COM 00287Y109 115,641 -2,955 -2.49 13,026 1.50 2.1857
2021-04-30 2021-03-31 13F AbbVie COM 00287Y109 118,596 795 0.67 12,834 1.68 2.3139
2021-01-29 2020-12-31 13F AbbVie COM 00287Y109 117,801 560 0.48 12,622 22.91 2.4394
2020-10-19 2020-09-30 13F AbbVie COM 00287Y109 117,241 -6,876 -5.54 10,269 -15.73 2.1640
2020-08-03 2020-06-30 13F AbbVie COM 00287Y109 124,117 755 0.61 12,186 29.65 2.6676
2020-04-30 2020-03-31 13F AbbVie COM 00287Y109 123,362 -847 -0.68 9,399 -14.53 2.5155
2020-01-16 2019-12-31 13F AbbVie COM 00287Y109 124,209 -4,935 -3.82 10,997 12.46 2.3990
2019-11-06 2019-09-30 13F AbbVie COM 00287Y109 129,144 -1,795 -1.37 9,779 2.70 2.3529
2019-07-22 2019-06-30 13F AbbVie COM 00287Y109 130,939 610 0.47 9,522 -9.34 2.3417
2019-05-07 2019-03-31 13F AbbVie COM 00287Y109 130,329 -2,300 -1.73 10,503 -14.10 2.6625
2019-02-12 2018-12-31 13F AbbVie COM 00287Y109 132,629 -1,909 -1.42 12,227 -3.91 3.4697
2018-11-08 2018-09-30 13F AbbVie COM 00287Y109 134,538 31,650 30.76 12,725 33.48 2.9072
2018-08-03 2018-06-30 13F AbbVie COM 00287Y109 102,888 6,400 6.63 9,533 4.38 2.3986
2018-05-11 2018-03-31 13F AbbVie COM 00287Y109 96,488 0 0.00 9,133 -2.12 2.4440
2018-03-01 2017-12-31 13F AbbVie COM 00287Y109 96,488 -75 -0.08 9,331 8.74 2.3755
2017-11-14 2017-09-30 13F AbbVie COM 00287Y109 96,563 3,091 3.31 8,581 26.60 2.3424
2017-08-14 2017-06-30 13F AbbVie COM 00287Y109 93,472 2,200 2.41 6,778 13.97 1.9784
2017-05-11 2017-03-31 13F AbbVie COM 00287Y109 91,272 405 0.45 5,947 7.58 1.7981
2017-02-10 2016-12-31 13F AbbVie COM 00287Y109 90,867 5,295 6.19 5,528 2.43 1.6975
2016-11-08 2016-09-30 13F AbbVie COM 00287Y109 85,572 -190 -0.22 5,397 1.64 1.8908
2016-08-15 2016-06-30 13F AbbVie COM 00287Y109 85,762 0 0.00 5,310 8.39 1.6757
2016-05-13 2016-03-31 13F/A-1 AbbVie COM 00287Y109 85,762 14,259 19.94 4,899 15.65 1.5743
2016-05-09 2016-03-31 13F AbbVie COM 00287Y109 85,762 4,899
2016-02-09 2015-12-31 13F AbbVie COM 00287Y109 71,503 23,025 47.50 4,236 60.58 1.4036
2015-11-05 2015-09-30 13F AbbVie COM 00287Y109 48,478 1,350 2.86 2,638 -16.70 0.9237
2015-08-11 2015-06-30 13F AbbVie COM 00287Y109 47,128 3,500 8.02 3,167 24.00 1.0342
2015-05-12 2015-03-31 13F AbbVie COM 00287Y109 43,628 12,600 40.61 2,554 25.81 0.8295
2015-02-06 2014-12-31 13F AbbVie COM 00287Y109 31,028 13,029 72.39 2,030 95.19 0.6453
2014-11-14 2014-09-30 13F AbbVie COM 00287Y109 17,999 7,050 64.39 1,040 68.28 0.3387
2014-08-14 2014-06-30 13F AbbVie COM 00287Y109 10,949 -75 -0.68 618 8.99 0.2066
2014-05-15 2014-03-31 13F AbbVie COM 00287Y109 11,024 -100 -0.90 567 -3.41 0.1975
2014-02-18 2013-12-31 13F AbbVie COM 00287Y109 11,124 -885 -7.37 587 9.31 0.2105
2013-11-25 2013-09-30 13F AbbVie COM 00287Y109 12,009 600 5.26 537 13.77 0.2094
2013-08-13 2013-06-30 13F AbbVie COM 00287Y109 11,409 11,409 472 0.1912
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.